Health Care › Surgical And Medical Instruments And Apparatus

NURO Stock Price Correlated With NeuroMetrix Financials

NURO Stock Price vs. Quarterly

Enable JavaScript to see charts like this:

log linear

Income Statement

Cash Flow

Balance Sheet

NURO Income Statement

Enable JavaScript and reload

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Gross Profit:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Income Taxes:

Net Income:

Earnings Per Share, Diluted:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

Shares Outstanding, Diluted Avg:

Common Stock Shares Outstanding:

NURO Cash Flow

Enable JavaScript and reload

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Repurchases/Buybacks Common Stock:

Issuance of Long-term Debt:

Cash Dividends Paid:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Purchases of Businesses, Net of Cash:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

NURO Balance Sheet

Enable JavaScript and reload

Cash and Cash Equivalents:

Short-Term Investments:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Long-Term Liabilities:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Vanguard Group

350,138 sh

109 sh
0%

$514

-$463

Geode Capital Management

55,354 sh

$81

State Street

18,170 sh

$27

Northernrp

11,059 sh

$16

Tower Research Capital (Trc)

7,393 sh

7,176 sh
3307%

$11

$10

3,625 sh

Stephens Consulting

500 sh

Advisory Services Network

100 sh

Millennium Management

0 sh

-20,530 sh
-100%

Morgan Stanley

0 sh

-2,276 sh
-100%

-$3

Ifp Advisors

0 sh

-12 sh
-100%

-$1

Proequities.

0 sh

Free historical financial statements for NeuroMetrix Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2012. Compare with NURO stock chart to see long term trends.

Data imported from NeuroMetrix Inc. SEC filings. Check original filings before making any investment decision.